572 Appendices 290. Sebag F, Vaillant-Lombard J, Berbis J, Griset V, Henry JF, Petit P, et al. Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. The Journal of clinical endocrinology and metabolism. 2010;95:5281-5288. https://doi.org/10.1210/jc.2010-0766. 291. Kim DW. Computed tomography features of papillary thyroid carcinomas. Journal of computer assisted tomography. 2014;38:936-940. https://doi.org/10.1097/rct.0000000000000149. 292. Lee C, Chalmers B, Treister D, Adhya S, Godwin B, Ji L, et al. Thyroid lesions visualized on CT: sonographic and pathologic correlation. Academic radiology. 2015;22:203-209. https://doi.org/10.1016/j.acra.2014.08.007. 293. Treglia G, Caldarella C, Saggiorato E, Ceriani L, Orlandi F, Salvatori M, et al. Diagnostic performance of (99m)TcMIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 2013;44:70-78. https://doi. org/10.1007/s12020-013-9932-z. 294. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinology and metabolism clinics of North America. 2007;36:707-735, vi. https://doi.org/10.1016/j.ecl.2007.04.009. 295. Lumachi F, Varotto L, Borsato S, Tregnaghi A, Zucchetta P, Marzola MC, et al. Usefulness of 99mTc-pertechnetate scintigraphy and fine-needle aspiration cytology in patients with solitary thyroid nodules and thyroid cancer. Anticancer research. 2004;24:2531-2534. 296. Saggiorato E, Angusti T, Rosas R, Martinese M, Finessi M, Arecco F, et al. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. Journal of nuclear medicine. 2009;50:1785-1793. https://doi.org/10.2967/jnumed.109.064980. 297. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Identification of Hurthle cell tumor by singleinjection, double-phase scintigraphy with technetium-99m-sestamibi. Journal of nuclear medicine. 1995;36:778782. 298. Boi F, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, et al. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. European journal of endocrinology. 2003;149:493-498. 299. Hindie E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Urena P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201-1216. https://doi.org/10.1007/s00259-009-1131-z. 300. Wale A, Miles KA, Young B, Zammit C, Williams A, Quin J, et al. Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. European journal of nuclear medicine and molecular imaging. 2014;41:105-115. https://doi.org/10.1007/s00259-013-2546-0. 301. Madorin CA, Owen R, Coakley B, Lowe H, Nam KH, Weber K, et al. Comparison of radiation exposure and cost between dynamic computed tomography and sestamibi scintigraphy for preoperative localization of parathyroid lesions. JAMA Surg. 2013;148:500-503. https://doi.org/10.1001/jamasurg.2013.57. 302. Heller M, Zanocco K, Zydowicz S, Elaraj D, Nayar R, Sturgeon C. Cost-effectiveness analysis of repeat fine-needle aspiration for thyroid biopsies read as atypia of undetermined significance. Surgery. 2012;152:423-430. https://doi. org/10.1016/j.surg.2012.05.038. 303. Mitchell JC, Grant F, Evenson AR, Parker JA, Hasselgren PO, Parangi S. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery. 2005;138:1166-1174; discussion 1174-1165. https://doi.org/10.1016/j.surg.2005.08.031. 304. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [18F]-2-fluoro-2-deoxyd-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582-4594. https://doi.org/10.1002/ cncr.26085. 305. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294-299. https://doi.org/10.1067/msy.2003.71. 306. Sebastianes FM, Cerci JJ, Zanoni PH, Soares J, Jr., Chibana LK, Tomimori EK, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. The Journal of clinical endocrinology and metabolism. 2007;92:4485-4488. https://doi.org/10.1210/jc.2007-1043. 307. Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, et al. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World journal of surgery. 2010;34:1247-1253. https://doi.org/10.1007/ s00268-010-0398-3. 308. Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? American journal of otolaryngology. 2008;29:113-118. https://doi.org/10.1016/j.amjoto.2007.04.006. 309. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, et al. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012;22:165-172. https://doi.org/10.1089/thy.2011.0255.
RkJQdWJsaXNoZXIy MTk4NDMw